CTXR
Citius Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $15.07M
- Employees
- 23
- Latest publication
- 2026-09-29
About Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Financial statements
Income Quarterly
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,493,788USD | 1,667,298USD | 3,944,111USD | — | — | — | 155,926USD | — |
| Cost Of Revenue | 491,843USD | 328,878USD | 789,208USD | — | — | — | 54,835USD | — |
| Gross Profit | 1,001,945USD | 1,338,420USD | 3,154,903USD | — | — | — | -54,835USD | — |
| Research Development | 1,053,869USD | 1,633,518USD | 1,599,719USD | 92,800,000,000,000USD | 1,621,325,000,000USD | 3,766,525,000,000USD | 2,127,038USD | 92,800,000,000,000USD |
| Selling General Administrative | 6,149,173USD | 26,391,101USD | 5,720,727USD | — | — | — | 7,912,576USD | — |
| General And Administrative Expenses | 6,149,173USD | 26,391,101USD | 5,720,727USD | — | — | — | — | — |
| Total Operating Expenses | 12,734,019USD | 33,533,206USD | 12,174,111USD | 38,525,608,000,000USD | 8,788,007,000,000USD | 11,260,678,000,000USD | 10,039,614USD | 41,995,681,000,000USD |
| Operating Income | -11,732,074USD | -32,194,786USD | -9,019,208USD | — | — | — | -10,039,614USD | — |
| Total Other Income Expense Net | -294,533USD | 3,853,830USD | -110,441USD | — | — | — | 22,608USD | — |
| Interest Income | 116,691USD | 53,584USD | 45,097USD | — | — | — | 22,608USD | — |
| Interest Expense | 231,732USD | 33,031USD | 155,538USD | — | — | — | 0USD | — |
| Income Before Tax | -12,026,607USD | -28,340,956USD | -9,129,649USD | — | — | — | -10,017,006USD | — |
| Income Tax Expense | -107,347USD | -231,210USD | 264,240USD | 1,056,960,000,000USD | 264,240,000,000USD | 264,240,000,000USD | 264,240USD | 576,000,000,000USD |
| Net Income | -11,919,260USD | -28,109,746USD | -9,393,889USD | -39,740,269,000,000USD | -9,203,872,000,000USD | -11,511,505,000,000USD | -9,768,246USD | -39,425,839,000,000USD |
| Minority Interest | -3,056,417USD | -6,878,606USD | -1,173,104USD | — | — | — | 513,000USD | — |
| Net Income Applicable To Common Shares | -8,862,843USD | -21,231,140USD | -8,220,785USD | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — | — | 22,608USD | — |
| Tax Provision | — | — | — | — | — | — | 264,240USD | — |
| Net Income From Continuing Ops | — | — | — | — | — | — | -10,281,246USD | — |
| Ebit | — | — | — | — | — | — | -10,017,006USD | — |
| Ebitda | — | — | — | — | — | — | -9,962,171USD | — |
| Depreciation And Amortization | — | — | — | — | — | — | 54,835USD | — |
| Reconciled Depreciation | — | — | — | — | — | — | 54,835USD | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | Legacy providerLegacy | DisclosurePreliminary |
Income Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 214,250USD | 209,611USD | 194,316USD | 179,677USD | 164,868USD | 152,364USD | 893USD | 1,753USD |
| Gross Profit | -214,250USD | -209,611USD | -194,316USD | -179,677USD | -164,868USD | -152,364USD | -893USD | -1,753USD |
| Research Development | 9,156,474USD | 11,906,601USD | 14,819,729USD | 17,655,482USD | 12,240,503USD | 8,812,810USD | 8,596,898USD | 6,562,925USD |
| Selling General Administrative | 18,532,843USD | 18,249,402USD | 21,912,289USD | 15,660,563USD | 11,291,391USD | 8,897,875USD | 7,001,463USD | 7,226,218USD |
| Unclassified Operating Expenses | 10,622,041USD | 11,839,678USD | — | — | — | — | — | — |
| Total Operating Expenses | 38,311,358USD | 41,995,681USD | 36,732,018USD | 33,316,045USD | 23,531,894USD | 17,710,685USD | 15,598,361USD | 13,789,143USD |
| Operating Income | -38,525,608USD | -41,995,681USD | -36,732,018USD | -33,316,045USD | -23,531,894USD | -17,710,685USD | -15,598,361USD | -13,789,143USD |
| Interest Income | 110,081USD | 758,000USD | 1,179,417USD | 251,399USD | 261,825USD | 68,066USD | 52,660USD | 0USD |
| Interest Expense | 267,782USD | — | — | 251,399USD | 10,839USD | 15,673USD | 16,443USD | 15,838USD |
| Net Interest Income | -157,701USD | 758,000USD | 1,179,417USD | 251,399USD | 250,986USD | 52,393USD | 36,217USD | -15,838USD |
| Income Before Tax | -38,683,309USD | -38,849,839USD | -31,966,912USD | -33,064,646USD | -23,054,434USD | -17,548,085USD | -15,562,144USD | -12,536,638USD |
| Income Tax Expense | 1,056,960USD | 576,000USD | 576,000USD | 576,000USD | 70,756USD | 125,880USD | 16,443USD | 1,284,181USD |
| Tax Provision | 1,056,960USD | 576,000USD | 576,000USD | 576,000USD | 0USD | 0USD | 0USD | 0USD |
| Net Income | -37,433,911USD | -39,138,839USD | -32,542,912USD | -33,640,646USD | -23,125,190USD | -17,548,085USD | -15,578,587USD | -12,536,638USD |
| Net Income From Continuing Ops | -39,740,269USD | -39,425,839USD | -32,542,912USD | -33,640,646USD | -23,054,434USD | -17,548,085USD | -15,562,144USD | -12,536,638USD |
| Ebit | -38,415,527USD | -38,849,841USD | -31,966,911USD | -33,064,646USD | -23,043,592USD | -17,532,409USD | -15,545,701USD | -13,789,143USD |
| Ebitda | -38,201,277USD | -38,640,230USD | -31,772,595USD | -32,884,969USD | -22,878,724USD | -17,380,045USD | -15,544,808USD | -13,787,390USD |
| Depreciation And Amortization | 214,250USD | 209,611USD | 194,316USD | 179,677USD | 164,868USD | 152,364USD | 893USD | 1,753USD |
| Reconciled Depreciation | 214,250USD | 209,611USD | 194,316USD | 179,677USD | 164,868USD | 152,364USD | 893USD | 1,753USD |
| Total Other Income Expense Net | -157,701USD | 3,145,842USD | 4,765,106USD | 251,399USD | 477,460USD | 162,600USD | 36,217USD | 1,252,505USD |
| Minority Interest | 2,306,358USD | 287,000USD | 0USD | — | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -33,640,646USD | -24,505,310USD | -17,548,085USD | -15,562,144USD | -12,536,638USD |
| Non Operating Income Net Other | — | — | — | — | 488,299USD | 178,273USD | 52,660USD | 1,268,343USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 142,255,198USD | 132,540,579USD | 140,391,730USD | 130,938,025USD | 127,676,859USD | 121,481,411USD | 120,703,457USD | 116,651,751USD |
| Cash And Equivalents | 17,007,523USD | 4,590,174USD | 7,721,393USD | 4,252,290USD | 6,089,126USD | 26,410USD | 1,100,079USD | 3,251,880USD |
| Total Current Assets | 43,331,363USD | 31,685,701USD | 37,945,133USD | 27,934,473USD | 24,611,269USD | 18,374,454USD | 18,327,187USD | 14,220,646USD |
| Other Non Current Assets | 98,170,796USD | 100,060,360USD | 101,611,420USD | 102,184,858USD | 102,184,858USD | 102,184,858USD | 102,184,858USD | 102,184,858USD |
| Total Liabilities | 66,346,742USD | 63,456,026USD | 46,923,760USD | 53,410,425USD | 60,115,929USD | 57,905,619USD | 51,783,998USD | 42,549,921USD |
| Total Current Liabilities | 51,649,351USD | 55,015,569USD | 38,207,120USD | 44,914,740USD | 51,842,452USD | 49,876,642USD | 44,805,958USD | 35,814,803USD |
| Other Current Liabilities | 25,913,962USD | 24,138,264USD | 4,693,307USD | 4,190,253USD | 8,523,675USD | 8,779,244USD | 6,242,178USD | 17,027USD |
| Total Stockholder Equity | 66,613,132USD | 61,541,536USD | 79,958,162USD | 67,550,178USD | 65,058,550USD | 60,659,412USD | 65,408,079USD | 70,077,450USD |
| Total Equity Including Noncontrolling Interest | 75,908,456USD | 69,084,553USD | 93,467,970USD | 77,527,600USD | 67,560,930USD | 63,575,792USD | 68,919,459USD | 74,101,830USD |
| Short Long Term Debt | 300,000,000USD | 300,000,000USD | 300,000,000USD | 300,000,000USD | 300,000,000USD | 300,000,000USD | 300,000,000USD | — |
| Net Receivables | 686,235USD | 1,079,055USD | 4,049,111USD | — | — | — | — | — |
| Inventory | 22,625,945USD | 22,659,590USD | 22,639,342USD | 22,286,693USD | 17,208,967USD | 15,339,253USD | 14,381,369USD | — |
| Property Plant Equipment Net | 753,039USD | 794,518USD | 835,177USD | 818,694USD | 880,732USD | 922,099USD | 191,412USD | 246,247USD |
| Goodwill | 9,346,796USD | 9,346,796USD | 9,346,796USD | 9,346,796USD | 9,346,796USD | 9,346,796USD | 9,346,796USD | 9,346,796USD |
| Accounts Payable | 8,037,899USD | 9,453,803USD | 11,021,412USD | 13,693,692USD | 10,094,042USD | 9,368,234USD | 7,364,120USD | 4,927,211USD |
| Short Term Debt | 176,170USD | 171,495USD | 148,006USD | 88,348USD | 114,694USD | 145,098USD | 204,569USD | 241,547USD |
| Common Stock | 27,452USD | 22,376USD | 22,376USD | 18,068USD | 14,475USD | 8,761USD | 7,727USD | 7,247USD |
| Retained Earnings | -277,118,897USD | -268,256,054USD | -247,024,914USD | -238,804,129USD | -230,844,841USD | -222,054,969USD | -211,138,464USD | -201,370,218USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 130,938,025USD | 116,651,751USD | 103,611,150USD | 113,999,302USD | 142,429,059USD | 43,773,655USD | 28,986,394USD | 31,050,524USD |
| Cash And Equivalents | 4,252,290USD | 3,251,880USD | — | — | — | — | — | — |
| Total Current Assets | 27,934,473USD | 14,220,646USD | 34,370,434USD | 44,564,270USD | 72,814,350USD | 13,981,985USD | 7,941,915USD | 10,060,078USD |
| Other Non Current Assets | 102,184,858USD | 102,184,858USD | — | — | — | — | — | — |
| Total Liabilities | 53,410,425USD | 42,549,921USD | — | — | — | — | — | — |
| Total Current Liabilities | 44,914,740USD | 35,814,803USD | 5,778,997USD | 4,530,012USD | 3,982,292USD | 4,097,133USD | 4,607,722USD | 3,184,840USD |
| Other Current Liabilities | 4,190,253USD | 17,027USD | — | — | — | — | — | — |
| Total Stockholder Equity | 67,550,178USD | 70,077,450USD | 90,831,108USD | 102,825,865USD | 132,182,353USD | 33,670,668USD | 24,378,672USD | 27,865,684USD |
| Total Equity Including Noncontrolling Interest | 77,527,600USD | 74,101,830USD | — | — | — | — | — | — |
| Short Long Term Debt | 300,000,000USD | — | — | — | — | 172,970USD | 172,970USD | 172,970USD |
| Inventory | 22,286,693USD | — | 0USD | — | — | — | — | — |
| Property Plant Equipment Net | 818,694USD | 246,247USD | 455,858USD | 650,174USD | 829,851USD | 987,781USD | 590USD | 1,483USD |
| Goodwill | 9,346,796USD | 9,346,796USD | — | — | — | — | — | — |
| Accounts Payable | 13,693,692USD | 4,927,211USD | 2,927,334USD | 1,165,378USD | 1,277,095USD | 1,856,235USD | 2,713,542USD | 1,573,444USD |
| Short Term Debt | 88,348USD | 241,547USD | 436,760USD | 393,978USD | 354,474USD | 331,970USD | 172,970USD | 172,970USD |
| Common Stock | 18,068USD | 7,247USD | 158,858USD | 146,211USD | 145,979USD | 55,577USD | 28,930USD | 16,199USD |
| Retained Earnings | -238,804,129USD | -201,370,218USD | -162,231,379USD | -129,688,467USD | -96,047,821USD | -70,593,867USD | -55,819,982USD | -40,257,838USD |
| Intangible Assets | — | — | 59,400,000USD | 59,400,000USD | 59,400,000USD | 19,400,000USD | 19,400,000USD | 19,400,000USD |
| Other Current Assets | — | — | 7,889,506USD | 2,852,580USD | 2,741,404USD | 122,237USD | 48,111USD | 57,732USD |
| Total Liab | — | — | 12,179,662USD | 10,573,057USD | 9,646,326USD | 10,102,987USD | 4,607,722USD | 3,184,840USD |
| Other Current Liab | — | — | 2,414,903USD | 2,970,656USD | 2,350,723USD | 1,908,928USD | 1,721,210USD | 1,438,426USD |
| Capital Stock | — | — | 158,858USD | 146,211USD | 145,979USD | 55,577USD | 28,930USD | 16,199USD |
| Good Will | — | — | 9,346,796USD | 9,346,796USD | 9,346,796USD | 9,346,796USD | 1,586,796USD | 1,586,796USD |
| Other Assets | — | — | 1USD | 38,062USD | 38,062USD | 57,093USD | 57,093USD | 2,167USD |
| Cash | — | — | 26,480,928USD | 41,711,690USD | 70,072,946USD | 13,859,748USD | 7,893,804USD | 9,184,003USD |
| Cash And Short Term Investments | — | — | 26,480,928USD | 41,711,690USD | 70,072,946USD | 13,859,748USD | 7,893,804USD | 9,184,003USD |
| Net Debt | — | — | -25,999,683USD | -41,033,456USD | -69,217,475USD | -12,507,725USD | -7,720,834USD | -9,011,033USD |
| Short Long Term Debt Total | — | — | 481,245USD | 678,234USD | 855,471USD | 1,352,023USD | 172,970USD | 172,970USD |
| Property Plant Equipment Gross | — | — | 455,858USD | 650,174USD | 829,851USD | 987,781USD | 590USD | 1,483USD |
| Common Stock Shares Outstanding | — | — | 10,086,267shares | 9,738,827shares | 7,239,939shares | 2,611,017shares | 1,344,124shares | 715,458shares |
| Non Current Assets Total | — | — | 69,240,715USD | 69,435,032USD | 69,614,709USD | 29,791,670USD | 21,044,479USD | 20,990,446USD |
| Non Current Liabilities Total | — | — | 6,400,665USD | 6,043,045USD | 5,664,034USD | 6,005,854USD | 4,985,800USD | 1,746,414USD |
| Non Currrent Assets Other | — | — | -44,876,939USD | 39,969,062USD | 38,062USD | 57,093USD | 57,093USD | 2,167USD |
| Net Working Capital | — | — | 28,591,437USD | 40,034,258USD | 68,832,058USD | 9,884,852USD | 3,334,193USD | 6,875,238USD |
| Unclassified Non Current Liabilities | — | — | 6,400,665USD | -5,561,800USD | -4,985,800USD | -4,985,800USD | — | 1,746,414USD |
| Unclassified Equity | — | — | 252,744,771USD | 232,221,910USD | 227,938,216USD | 104,153,381USD | 80,140,794USD | 68,091,124USD |
| Deferred Long Term Liab | — | — | — | 5,561,800USD | 4,985,800USD | 4,985,800USD | — | — |
| Other Liab | — | — | — | 5,561,800USD | 4,985,800USD | 4,985,800USD | 4,985,800USD | — |
| Non Current Liabilities Other | — | — | — | 481,245USD | 678,234USD | 855,471USD | — | — |
| Net Tangible Assets | — | — | — | 102,825,865USD | 132,182,353USD | 33,670,668USD | -1,593,924USD | 6,878,888USD |
| Unclassified Non Current Assets | — | — | — | -39,969,062USD | — | — | — | — |
| Long Term Debt | — | — | — | — | — | 164,583USD | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | 0USD | — | 0USD |
| Net Receivables | — | — | — | — | — | — | — | 818,343USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -11,919,260USD | -28,109,746USD | — | -39,740,269,000,000USD | -9,203,872,000,000USD | -11,511,505,000,000USD | — | -39,425,839,000,000USD |
| Stock Based Compensation | 3,810,665USD | 3,788,275USD | 4,280,227USD | 10,836,291,000,000USD | 2,719,674,000,000USD | 2,702,031,000,000USD | 2,524,824USD | 11,839,678,000,000USD |
| Investing Cash Flow | -7,000,000USD | -5,000,000USD | -4,400,000USD | -5,750,000,000,000USD | — | — | — | -5,000,000,000,000USD |
| Financing Cash Flow | 42,741,646USD | 19,646,727USD | 20,877,925USD | 33,303,148,000,000USD | 17,509,194,000,000USD | 6,039,858,000,000USD | 2,574,051USD | 9,972,327,000,000USD |
| Change In Cash | 12,755,233USD | 337,884USD | 3,469,103USD | 1,000,410,000,000USD | 2,837,246,000,000USD | -3,225,470,000,000USD | -2,151,801USD | -23,229,048,000,000USD |
| End Cash Flow | 17,007,523USD | 4,590,174USD | 7,721,393USD | — | 6,089,126,000,000USD | 26,410,000,000USD | 1,100,079USD | — |
| Deferred Income Tax | — | — | 264,240USD | — | — | — | 264,240USD | — |
| Change To Inventory | — | — | -352,649USD | — | — | — | -6,112,603USD | — |
| Change To Liabilities | — | — | -2,169,226USD | — | — | — | 8,662,060USD | — |
| Change In Working Capital | — | — | -3,222,981USD | — | — | — | -3,675,694USD | — |
| Operating Cash Flow | — | — | -13,008,822USD | — | — | — | -4,725,852USD | — |
| Depreciation | — | — | — | 1,432,000,000USD | 1,432,000,000USD | 1,157,000,000USD | — | 1,432,000,000USD |
| Source | DisclosurePreliminary | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosurePreliminary |
Cash flow YTD
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD |
|---|---|---|---|---|
| Stock Based Compensation | 11,879,167USD | 8,068,502USD | 7,946,529USD | 5,226,855USD |
| Deferred Income Tax | -74,317USD | 33,030USD | 792,720USD | 528,480USD |
| Change To Account Receivables | -686,235USD | — | — | — |
| Change To Inventory | -339,252USD | -372,897USD | -8,940,201USD | -7,070,487USD |
| Change To Liabilities | 14,305,416USD | 15,708,122USD | 13,673,479USD | 13,203,240USD |
| Change In Working Capital | -8,102,407USD | -4,303,226USD | -2,292,347USD | -1,674,416USD |
| Operating Cash Flow | -22,986,413USD | -14,308,843USD | -14,671,948USD | -9,265,328USD |
| Investing Cash Flow | -7,000,000USD | -5,000,000USD | — | — |
| Financing Cash Flow | 42,741,646USD | 19,646,727USD | 17,509,194USD | 6,039,858USD |
| Change In Cash | 12,755,233USD | 337,884USD | 2,837,246USD | -3,225,470USD |
| End Cash Flow | 17,007,523USD | 4,590,174USD | 6,089,126USD | 26,410USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Stock Based Compensation | 10,836,291USD | 11,839,678USD | 6,616,705USD | 3,905,954USD | 1,454,979USD | 803,261USD | 715,983USD | 779,701USD |
| Deferred Income Tax | 1,056,960USD | 576,000USD | — | — | — | — | — | — |
| Change To Inventory | -12,649,207USD | -2,133,871USD | 0USD | — | — | — | -818,343USD | — |
| Change To Liabilities | 12,939,707USD | 1,540,604USD | — | 527,968USD | 129,861USD | -685,261USD | 1,406,439USD | 971,013USD |
| Change In Working Capital | -2,819,297USD | -133,994USD | -4,006,321USD | 239,555USD | -2,717,270USD | -866,968USD | 2,195,920USD | 509,846USD |
| Operating Cash Flow | -26,552,738USD | -28,201,375USD | — | — | — | — | — | — |
| Investing Cash Flow | -5,750,000USD | -5,000,000USD | — | — | — | — | — | — |
| Financing Cash Flow | 33,303,148USD | 9,972,327USD | — | — | — | — | — | — |
| Change In Cash | 1,000,410USD | -23,229,048USD | -15,230,762USD | -28,361,256USD | 56,213,198USD | 5,965,944USD | -1,290,199USD | 5,979,895USD |
| End Cash Flow | 4,252,290USD | 3,251,880USD | — | — | — | — | — | — |
| Depreciation | — | 1,432USD | 194,316USD | 179,677USD | 164,868USD | 152,364USD | 893USD | 1,753USD |
| Other Non Cash Items | — | 2,387,842USD | 102,000USD | 378,204USD | 68,000USD | 528,770USD | 211,597USD | 377,200USD |
| Net Income | — | — | -32,542,912USD | -33,640,646USD | -23,054,434USD | -17,548,085USD | -15,562,144USD | -12,536,638USD |
| Total Cash From Operating Activities | — | — | -29,060,212USD | -28,361,256USD | -24,250,414USD | -16,930,658USD | -12,437,751USD | -11,318,138USD |
| Capital Expenditures | — | — | -2USD | 0USD | -40,006,938USD | -1,831USD | -1,831USD | -1,831USD |
| Free Cash Flow | — | — | -29,060,212USD | -28,361,256USD | -64,257,352USD | -16,932,489USD | -12,437,751USD | -11,318,138USD |
| Investments | — | — | 0USD | -40,000,000USD | -40,006,938USD | -1,831USD | 0USD | 0USD |
| Total Cash From Financing Activities | — | — | 13,829,450USD | 31,267USD | 120,470,550USD | 22,898,433USD | 11,147,552USD | 17,298,033USD |
| Issuance Of Capital Stock | — | — | 13,798,183USD | 0USD | 89,430,752USD | 15,577,301USD | 11,124,336USD | 16,172,885USD |
| Begin Period Cash Flow | — | — | 41,711,690USD | 70,072,946USD | 13,859,748USD | 7,893,804USD | 9,184,003USD | 3,204,108USD |
| End Period Cash Flow | — | — | 26,480,928USD | 41,711,690USD | 70,072,946USD | 13,859,748USD | 7,893,804USD | 9,184,003USD |
| Other Cashflows From Financing Activities | — | — | 31,267USD | — | 31,212,768USD | 7,156,549USD | 23,216USD | 1,125,148USD |
| Net Borrowings | — | — | — | 0USD | -172,470USD | 164,583USD | 164,583USD | 164,583USD |
| Cash And Cash Equivalents Changes | — | — | — | -28,361,256USD | 56,213,198USD | 5,965,944USD | -1,290,199USD | 5,979,895USD |
| Total Cashflows From Investing Activities | — | — | — | — | -40,006,938USD | -1,831USD | -1,831USD | -1,831USD |
| Sale Purchase Of Stock | — | — | — | — | 120,643,020USD | 7,156,549USD | 23,216USD | 17,298,030USD |
| Other Cashflows From Investing Activities | — | — | — | — | -40,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | 40,046,938USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | -31,212,768USD | 8,420,752USD | 10,936,537USD | -1,289,728USD |
| Change To Account Receivables | — | — | — | — | — | — | 818,343USD | -818,343USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.